These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2189332)

  • 1. [Captopril treatment of neonatal arterial hypertension].
    Moreno Villares JM; Barrio Andrés C; Gutiérrez Junquera C; Torres Mohedas J
    An Esp Pediatr; 1990 Mar; 32(3):253-6. PubMed ID: 2189332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term effect of captopril in hypertension with chronic renal failure.
    Gassia JP; Durand D; Ton That H; Degroc F; Suc JM
    Proc Eur Dial Transplant Assoc; 1980; 17():719-24. PubMed ID: 7017704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
    Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
    Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitor treatment of hypertension in infancy and childhood.
    Sigström L; Aurell M; Jodal U
    Scand J Urol Nephrol Suppl; 1984; 79():107-9. PubMed ID: 6089308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group.
    Mirkin BL; Newman TJ
    Pediatrics; 1985 Jun; 75(6):1091-100. PubMed ID: 3889818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
    Christensen KL; Jespersen LT; Mulvany MJ
    J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of captopril in periarteritis nodosa with arterial hypertension and renal failure (author's transl)].
    Guillevin L; Leenhardt A; Herson S; Bletry O; Godeau P
    Nouv Presse Med; 1981 Apr; 10(19):1592-3. PubMed ID: 6116493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nifedipine in hypertension not controlled by converting enzyme inhibitor and diuretic.
    Mimran A; Ribstein J
    Postgrad Med J; 1986; 62 Suppl 1():135-8. PubMed ID: 3022271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril in the treatment of moderate to severe hypertension.
    Kaul UA; Chutani SK; Verma IC; Khalilullah M
    J Assoc Physicians India; 1989 Feb; 37(2):152-4. PubMed ID: 2681137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and effects of captopril therapy in childhood.
    Bendig L; Temesvári A
    Acta Physiol Hung; 1988; 72 Suppl():121-9. PubMed ID: 3075397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.